...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >PREPARATION AND EVALUATION OF METRONIDAZOLE SUSTAINED RELEASE FLOATING TABLETS
【24h】

PREPARATION AND EVALUATION OF METRONIDAZOLE SUSTAINED RELEASE FLOATING TABLETS

机译:甲硝唑缓释漂浮片剂的制备和评价

获取原文
           

摘要

Objective: The objective of the present study is the preparation of metronidazole (MZ) floating tablets that are designed to retain in the stomach for a long time for better eradication of Helicobacter Pylori (H. pylori) , a main cause of peptic ulcer disease. Methods: Synthetic and natural polymers were studied for their floating potential in the presence of sodium bicarbonate, namely: hydroxypropyl methylcellulose (HPMC), carbopol 974P, sodium alginate{low and medium viscosity (LV & MV) grades}, locust gum and guar gum. Hardness, floating ability, release profiles and kinetics as well as DSC / FT-IR were studied. Results: Results of both DSC and FT-IR spectroscopy revealed that there was no interaction between the drug and any of the proposed polymers. Carbopol 974P based tablets showed an unacceptable floating lag time (2 h) and did not maintain good tablet integrity. All other formulas were able to float after few seconds and showed buoyancy for more than 24 h. Meanwhile, sustained profiles of MZ release were obtained. After 6 h the amount of MZ released were: 75.11 %, 61.26 %, 54.56 %, 54.25 % and 43.42 % from sodium alginate-LV, HPMC-K4M, guar gum, locust gum and sodium alginate-MV based tablets, respectively. Kinetically, among the 5 assessed models, the release pattern of MZ from the tablets fitted best to Zero order and Hixson & Crowell Cube-Root models. Conclusion: These stomach targeted dosage forms could maintain the minimum inhibitory concentration for sufficient time to allow for local eradication and thereby achieve better efficiency of therapy with improved patient compliance, reduced costs and minimized side effects caused by immediate release dosage forms. Keywords : Metronidazole, Floating tablets, HPMC-K4M, Alginates, Gums, Drug‐polymer interaction, Release kinetics.
机译:目的:本研究的目的是制备甲硝唑(MZ)漂浮片剂,该片剂旨在长时间保留在胃中,以更好地根除幽门螺杆菌(幽门螺杆菌),后者是消化性溃疡疾病的主要原因。方法:研究了在碳酸氢钠存在下合成和天然聚合物的漂浮潜力,即:羟丙基甲基纤维素(HPMC),carbopol 974P,海藻酸钠{低和中粘度(LV&MV)级},刺槐胶和瓜尔豆胶。研究了硬度,漂浮能力,释放曲线和动力学以及DSC / FT-IR。结果:DSC和FT-IR光谱的结果均表明,该药物与任何拟议的聚合物之间没有相互作用。基于Carbopol 974P的片剂显示出不可接受的漂浮滞后时间(2小时),并且不能保持良好的片剂完整性。所有其他配方在几秒钟后便能漂浮并显示浮力超过24小时。同时,获得了MZ释放的持续曲线。 6小时后,从藻酸钠-LV,HPMC-K4M,瓜尔胶,刺槐胶和藻酸钠-MV基片剂中分别释放出MZ的量为:75.11%,61.26%,54.56%,54.25%和43.42%。从动力学上说,在5个评估模型中,片剂中MZ的释放模式最适合零阶模型和Hixson&Crowell Cube-Root模型。结论:这些以胃为靶标的剂型可以在足够长的时间内保持最小抑菌浓度,以允许局部根除,从而通过提高患者的依从性,降低成本并将因速释剂型引起的副作用降至最低而达到更高的治疗效率。关键词:甲硝唑漂浮片剂HPMC-K4M海藻酸盐胶,药物-聚合物相互作用,释放动力学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号